Oxodil Combo (Budesonide, Formoterol Fumarate Dihydrate)

Budesonide, the active ingredient in Oxodil Combo, is a corticosteroid presented as a combination inhalation therapy for respiratory use. It reduces inflammation and helps control symptoms in chronic airway diseases. Oxodil Combo, the brand name, combines budesonide with formoterol fumarate dihydrate to provide both anti‑inflammatory and long‑acting bronchodilator effects.

GNH USA supplies Oxodil Combo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Oxodil Combo is a fixed‑dose inhaled medication that acts on the airways to manage chronic obstructive pulmonary disease and asthma. - Asthma: improves control of symptoms and reduces the frequency of exacerbations. - Chronic obstructive pulmonary disease (COPD): enhances lung function and decreases rescue‑inhaler use. - Exercise‑induced bronchoconstriction: prevents airway narrowing during physical activity.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Throat irritation: mild discomfort or scratchy feeling in the throat. - Hoarseness: temporary change in voice quality. - Cough: transient increase in coughing after inhalation. - Oral candidiasis: fungal growth in the mouth, often mild. - Headache: occasional mild headache. - Nasal congestion: feeling of a blocked nose.

Serious or Rare Side Effects: - Paradoxical bronchospasm: sudden worsening of breathing difficulty. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Pneumonia: signs of lung infection such as fever and cough. - Glaucoma or cataract progression: eye pressure changes or lens opacity. - Adrenal suppression: signs of low cortisol especially with high‑dose or prolonged use. - Osteoporosis: reduced bone density with long‑term therapy.

When prescribing Oxodil Combo, clinicians should consider several safety aspects. - Monitor lung function: assess response and adjust therapy as needed. - Use a spacer: reduces oropharyngeal deposition and lowers risk of candidiasis. - Review concomitant steroids: avoid excessive systemic corticosteroid exposure. - Assess infection risk: be vigilant for signs of pneumonia or oral thrush. - Educate on inhaler technique: proper use maximizes benefit and minimizes side effects. - Store at ambient temperature: keep below 25°C, protect from moisture and direct sunlight.

Oxodil Combo may interact with other medicines that affect the respiratory system or steroid metabolism.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase systemic budesonide exposure. - Monoamine oxidase inhibitors (MAOIs): risk of additive cardiovascular effects with formoterol.

Moderate Interactions (Monitor Closely): - β‑blockers: may diminish bronchodilator response of formoterol. - Diuretics: can potentiate hypokalemia caused by β2‑agonists. - Anticholinergics: overlapping bronchodilator actions may require dose adjustment. - Theophylline: combined bronchodilation may increase risk of tachyarrhythmia.